Hepatic

INDICATION: Non-alcoholic steatohepatitis (NASH)

Patient sample and mouse studies suggest inhibiting the Notch pathway components HES1, γ secretase, MAML1 and NCSTN could help treat

Read the full 233 word article

User Sign In